source
- Rare disease drugmakers brace for potential Trump administration price cuts amid GOP push on health‑care fraudRare disease drugmakers are watching the Trump administration closely as proposals emerge that could force lower prices for their specialty therapies. The companies are exploring strategies to miti…
- Dimension raises $800 million for third fund to boost AI-driven biotech venturesDimension, a venture capital firm focused on the intersection of technology and biotech, announced the closing of its largest fund to date, raising $800 million for its third fund, called Dimension…